Anti-interferon-α receptor 1 antibodies attenuate inflammation and organ injury following hemorrhagic shock.

Authors:
Dr. Joaquin Cagliani, MD
Dr. Joaquin Cagliani, MD
The Feinstein Institute for Medical Research
PhD Candidate
Shock, Immunology, Molecular Medicine
Manhasset, NEW YORK | United States
Weng-Lang Yang
Weng-Lang Yang
United States
Joseph T McGinn
Joseph T McGinn
Staten Island University Hospital
United States
Zhimin Wang
Zhimin Wang
Institute of Chinese Materia Medica
China
Ping Wang
Ping Wang
Albert Einstein College of Medicine
United States

J Trauma Acute Care Surg 2019 May;86(5):881-890

From the Elmezzi Graduate School of Molecular Medicine, (J.C., W-L.Y., P.W.); Center for Immunology and Inflammation, (J.C., W-L.Y., Z.W., P.W.) The Feinstein Institute for Medical Research, Manhasset; Department of Surgery, Zucker School of Medicine at Hofstra/Northwell, (W-L.Y., J.T.M., P.W.) Hempstead, New York.

Background: Hemorrhagic shock (HS) is a life-threatening condition resulting from rapid and significant loss of intravascular volume, leading to hemodynamic instability and death. Inflammation contributes to the multiple organ injury in HS. Type I interferons (IFNs), such as IFN-α and IFN-β, are a family of cytokines that regulate the inflammatory response through binding to IFN-α receptor (IFNAR) which consists of IFNAR1 and IFNAR2 chains. We hypothesized that type I IFNs provoke inflammation and worsen organ injury in HS.

Methods: Male C57BL/6 mice (20-25 g) underwent hemorrhage by controlled bleeding via the femoral artery to maintain a mean arterial pressure of 27 ± 2.5 mm Hg for 90 minutes, followed by resuscitation for 30 minutes with two times shed blood volume of Ringer's lactate solution containing 1 mg/kg body weight of anti-IFNAR1 antibody (Ab) or control isotype-matched IgG (IgG). Blood and tissue samples were collected at 20 hours after the resuscitation for various analyses.

Results: The expression of IFN-α and IFN-β mRNAs was significantly elevated in lungs and liver of the mice after HS. The IFNAR1-Ab treatment significantly decreased serum levels of organ injury markers lactate dehydrogenase and aspartate aminotransferase, as well as improved the integrity of lung and liver morphology, compared to the IgG control. The protein levels of proinflammatory cytokines TNF-α and IL-6, and mRNA expression of proinflammatory chemokines monocyte chemoattractant protein (MCP)-1, MCP-2, macrophage inflammatory protein 2 (MIP-2), and keratinocyte cytokine (KC) in the lungs of the HS mice were significantly decreased after treated with IFNAR1-Ab. Moreover, the myeloperoxidase activity and number of apoptotic cells in the lungs of HS mice treated with IFNAR1-Ab were decreased in comparison to the IgG control.

Conclusion: Administration of IFNAR1-Ab reduces inflammation and tissue injury. Thus, type I IFN signaling may be a potential therapeutic target for mitigating organ dysfunction in patients suffering from HS.

Study Type: Translational animal model.

Download full-text PDF

Source
http://dx.doi.org/10.1097/TA.0000000000002214DOI Listing
May 2019
1 Read
1.970 Impact Factor

Publication Analysis

Top Keywords

organ injury
16
hemorrhagic shock
8
injury type
8
ifn-α ifn-β
8
treated ifnar1-ab
8
lungs mice
8
organ
5
injury
5
minutes times
4
expression proinflammatory
4
mrna expression
4
times blood
4
resuscitation minutes
4
proinflammatory chemokines
4
chemokines monocyte
4
pressure minutes
4
blood volume
4
minutes resuscitation
4
volume ringer's
4
proinflammatory cytokines
4

Similar Publications